未找到相关数据
Neoadjuvant and adjuvant nivolumab (nivo) with anti-LAG3 antibody relatlimab (rela) for patients (pts) with resectable clinical stage III melanoma.
被引：34
作者：
Amaria, Rodabe Navroze
Postow, Michael A.
Tetzlaff, Michael T.
Ross, Merrick I.
Glitza, Isabella Claudia
McQuade, Jennifer Leigh
Wong, Michael K. K.
Gershenwald, Jeffrey E.
Goepfert, Ryan
Keung, Emily Zhi-Yun
Fisher, Sarah B.
Milton, Denai R.
Patel, Sapna Pradyuman
Diab, Adi
Simpson, Lauren
Davies, Michael A.
Wargo, Jennifer Ann
Burton, Elizabeth M.
Ariyan, Charlotte Eielson
Tawbi, Hussein Abdul-Hassan
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[3] UCSF, San Francisco, CA USA
[4] MD Anderson Canc Ctr, Houston, TX USA
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.9502
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9502
引用
收藏
页数：3
相关论文